Ciltron 100mg Tablet

Introduction

Ciltron is a prescription medication that contains the active ingredient cilostazol. It is available in tablet form and is commonly used to treat certain symptoms associated with peripheral arterial disease (PAD).

Uses

Ciltron is prescribed for individuals who have intermittent claudication, a condition characterized by pain, cramping, or weakness in the legs during physical activity. This medication helps improve blood flow to the legs, which can reduce the symptoms of intermittent claudication and increase the distance that can be walked without experiencing discomfort.

Dosage and Administration

Ciltron tablets are typically taken orally, with or without food. The dosage may vary depending on the individual’s medical condition and response to treatment. Follow the instructions provided by your healthcare professional and not exceed the recommended dose. If you have any questions about the dosage or administration of this medication, consult your doctor or pharmacist.

Mechanism of Action

Cilostazol, the active ingredient in Ciltron, works by inhibiting certain enzymes in the body called phosphodiesterase III. This inhibition helps to widen the blood vessels and reduce the stickiness of platelets, which can improve blood flow and prevent the formation of blood clots. By increasing blood flow, cilostazol can alleviate the symptoms associated with intermittent claudication.

Side Effects

Common side effects may include headache, diarrhea, dizziness, and abnormal stool color. These side effects are usually mild and temporary. However, if you experience any severe or persistent side effects, such as chest pain, shortness of breath, or signs of an allergic reaction, seek medical attention immediately.

Drug Interactions

Ciltron may interact with certain medications, including blood thinners, antiplatelet drugs, and certain antifungal or antibiotic medications. Inform your healthcare professional about all the medications you are currently taking, including prescription and over-the-counter drugs, herbal supplements, and vitamins. They can assess the potential for drug interactions and make any necessary adjustments to your treatment plan.

Precautions

Before starting treatment with Ciltron, inform your healthcare professional about any pre-existing medical conditions, especially if you have a history of heart disease, bleeding disorders, or liver or kidney problems. This medication may not be suitable for everyone, and your doctor can determine if it is appropriate for you based on your individual health status.

Storage

Patient Tips

• Take Ciltron exactly as prescribed by your healthcare professional. Do not adjust the dosage or stop taking the medication without consulting your doctor.
• If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and resume your regular dosing schedule.
• Follow a healthy lifestyle, including regular exercise, a balanced diet, and smoking cessation, as advised by your healthcare professional. These lifestyle changes can complement the effects of Ciltron in managing your condition.
• Attend regular follow-up appointments with your doctor to monitor your progress and discuss any concerns or questions you may have.
• If you have any questions or concerns about Ciltron or its usage, consult your healthcare professional or pharmacist for more information.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Cilostazol 100 mg tablets (Health Professionals SmPC) Available at:
• Cilostazol (Drugs.com) [Accessed 14 Jun. 2024] (online) Available at:
• cilostazol (RX) [Accessed 17 Jun. 2024] (online) Available at:
• Cilostazol (MedlinePlus) [Accessed 2 Jun. 2024] (online) Available at:
• Wardlaw JM, Woodhouse LJ, Mhlanga II, Oatey K, Heye AK, Bamford J, Cvoro V, Doubal FN, England T, Hassan A, Montgomery A, O’Brien JT, Roffe C, Sprigg N, Werring DJ, Bath PM; Lacunar Intervention Trial-2 (LACI-2) Investigator Group. Isosorbide Mononitrate and Cilostazol Treatment in Patients With Symptomatic Cerebral Small Vessel Disease: The Lacunar Intervention Trial-2 (LACI-2) Randomized Clinical Trial. JAMA Neurol. 2023 Jul 1;80(7):682-692. doi: 10.1001/jamaneurol.2023.1526. [Accessed 25 Jun. 2024] Available at: